Hepatic angiosarcoma – Life with Disease

Go back

Hepatic angiosarcoma is a rare and aggressive cancer that develops from the cells lining blood vessels in the liver. It represents a small fraction of liver cancers but poses significant challenges for diagnosis and treatment, often progressing rapidly and presenting symptoms that can easily be mistaken for other conditions.

Prognosis

Receiving a diagnosis of hepatic angiosarcoma can feel overwhelming, and it’s important to approach this conversation with sensitivity and honesty. The outlook for people with this disease is unfortunately quite serious, and understanding what to expect can help patients and families prepare emotionally and practically for the journey ahead.[1]

Hepatic angiosarcoma is known for its aggressive nature, meaning it grows and spreads quickly compared to many other cancers. Most patients diagnosed with this condition face a survival time measured in months rather than years. Research shows that the median overall survival—the point at which half of patients are still living—is approximately six months from the time of diagnosis. This statistic reflects the reality that many people are diagnosed when the disease is already advanced.[9][13]

When looking at longer time frames, the statistics remain challenging. Studies indicate that the one-year survival rate is around thirty percent, meaning that roughly three out of ten people diagnosed will still be alive a year later. The three-year survival rate drops to about eight percent, and the five-year survival rate is approximately five percent. These numbers emphasize how difficult this cancer is to treat over extended periods.[4]

A more recent study from an academic medical center found slightly different numbers, with two-year and five-year overall survival rates both at about 38.6 percent among patients receiving treatment. This suggests that some individuals, particularly those who can undergo aggressive surgical removal of the tumor, may have better outcomes than historical averages suggest.[9]

⚠️ Important
While statistics provide a general picture, every patient’s situation is unique. Some individuals have lived significantly longer than average, especially when diagnosed early and treated aggressively. Discussing your specific case with your healthcare team is essential for understanding your individual prognosis.

The prognosis for hepatic angiosarcoma is significantly worse compared to more common liver cancers like hepatocellular carcinoma, which is the most common type of liver cancer. Research comparing the two found that the average survival for hepatic angiosarcoma was 1.9 months, while hepatocellular carcinoma patients survived a median of 10.3 months. This dramatic difference highlights the particularly aggressive nature of angiosarcoma.[7]

Several factors influence how long someone might live after diagnosis. The most important factor is whether the cancer can be completely removed through surgery. Patients who undergo successful surgical removal with clean margins—meaning no cancer cells are left at the edges of the removed tissue—generally have better outcomes than those who cannot have surgery. Unfortunately, most patients are diagnosed when the disease has already spread or is too extensive for complete surgical removal.[9]

Another factor is the stage at diagnosis. Like other cancers, hepatic angiosarcoma is more treatable when caught early, but this rarely happens because early symptoms are vague or absent. By the time symptoms prompt medical attention, the disease is often advanced, which contributes to the poor prognosis.[2]

Natural Progression

Understanding how hepatic angiosarcoma develops and progresses without treatment helps explain why early detection is so critical. This cancer begins in the endothelial cells, which are the cells that form the inner lining of blood vessels throughout the body. When these cells in the liver’s blood vessels undergo changes in their DNA, they can begin to grow uncontrollably.[2]

Unlike normal cells that die when they become old or damaged, cancer cells continue to multiply. In hepatic angiosarcoma, these abnormal endothelial cells don’t just form a single mass. Instead, they often create multiple nodules or tumors throughout the liver. These abnormal cells also form new, irregular blood vessels that don’t function properly, contributing to the tumor’s growth and spread.[1]

The disease often begins silently, without causing noticeable symptoms. During this early phase, the cancer cells are multiplying and the tumor is growing, but it may not yet be large enough to interfere with liver function or cause pain. This is one reason why hepatic angiosarcoma is so often diagnosed late—there’s nothing prompting the person to seek medical attention.[3]

As the tumor continues to grow, it eventually becomes large enough to cause symptoms. These might include a feeling of fullness or pain in the upper right part of the abdomen where the liver is located. The growing mass can put pressure on surrounding organs and structures, leading to discomfort. Some people develop abdominal swelling as fluid accumulates in the abdomen, a condition called ascites.[1]

Without treatment, the liver’s function gradually deteriorates. The liver is responsible for many essential tasks, including filtering toxins from the blood, producing proteins needed for blood clotting, and processing nutrients. As more and more liver tissue is replaced by tumor, these functions become compromised. This can lead to jaundice, where the skin and eyes take on a yellowish color because the liver can’t properly process a substance called bilirubin.[2]

Hepatic angiosarcoma has a strong tendency to metastasize, meaning it spreads to other parts of the body. The cancer cells can break away from the original tumor and travel through the bloodstream or lymphatic system to distant organs. Common sites of spread include the lungs, spleen, bones, and other areas of the liver. Once the cancer has spread widely, treatment becomes even more difficult.[4]

One particularly dangerous aspect of the natural progression is that the tumor, being made up of abnormal blood vessels, is highly vascular and prone to bleeding. As it grows, the tumor can erode through the liver’s surface or into major blood vessels within the liver, causing severe internal bleeding. This represents a life-threatening emergency.[4]

Interestingly, despite the extensive tumor burden, liver function is often maintained until the very late stages of the disease. Standard liver function tests may remain relatively normal even when the cancer is advanced. This paradox further complicates early diagnosis, as routine blood tests might not raise red flags even when significant disease is present.[4]

Possible Complications

Hepatic angiosarcoma can lead to several serious complications, some of which can be life-threatening. Understanding these potential problems helps patients and families recognize warning signs that require immediate medical attention.

One of the most dangerous complications is spontaneous tumor rupture, which occurs when the tumor breaks open and causes severe bleeding inside the abdomen. This happens in fifteen to twenty-seven percent of patients with hepatic angiosarcoma, making it a relatively common and frightening complication. The rupture leads to blood accumulating in the abdominal cavity, a condition called hemoperitoneum, which can cause sudden, severe abdominal pain and a dangerous drop in blood pressure leading to shock.[4][6]

Several factors contribute to the risk of tumor rupture. The tumor’s highly vascular nature means it’s filled with abnormal, fragile blood vessels that can easily tear. Additionally, many patients develop low platelet counts (a condition called thrombocytopenia) and anemia, both of which affect the blood’s ability to clot properly. When rupture occurs, controlling the bleeding can be extremely difficult, even with emergency procedures like transcatheter arterial embolization, where doctors thread a catheter through blood vessels to block the bleeding source.[4]

The prognosis after tumor rupture is extremely poor. One analysis of four patients who experienced this complication found that the median survival was only twenty-three days following rupture, even when emergency measures were taken to stop the bleeding. This highlights how critical it is to monitor for signs of rupture, such as sudden severe pain, dizziness, rapid heartbeat, or fainting.[4]

The spleen, an organ located near the liver, is also at risk. Because of its proximity to the liver and its own rich blood supply, the spleen is a common site for metastasis from hepatic angiosarcoma. When cancer spreads to the spleen, it too can rupture, causing additional internal bleeding. This adds another layer of danger for patients with this disease.[4]

Another serious complication is liver failure. As the tumor progressively replaces healthy liver tissue, the liver becomes unable to perform its vital functions. Liver failure can cause a cascade of problems including jaundice, confusion or altered mental status (due to toxins building up in the bloodstream), easy bruising and bleeding, severe fatigue, and fluid accumulation in the abdomen and legs. Once liver failure develops, it’s often irreversible and can be fatal.[4]

Disseminated intravascular coagulation, often abbreviated as DIC, is another potential complication of hepatic angiosarcoma. This is a serious condition where the body’s clotting system becomes overactive throughout the bloodstream. Small blood clots form in blood vessels throughout the body, using up the platelets and clotting factors needed to control bleeding. This paradoxically leads to both excessive clotting in some areas and dangerous bleeding in others. DIC can develop in patients with various cancers, including hepatic angiosarcoma, and is a medical emergency requiring immediate treatment.[4]

⚠️ Important
Patients with hepatic angiosarcoma should seek immediate emergency care if they experience sudden, severe abdominal pain, signs of shock (dizziness, rapid heartbeat, cold and clammy skin), or any symptoms of internal bleeding. These could indicate tumor rupture or other life-threatening complications requiring urgent intervention.

As the cancer spreads to other organs, complications specific to those sites can develop. For example, when angiosarcoma metastasizes to the lungs, it can cause difficulty breathing, chest pain, and coughing. Spread to bones can cause severe pain and increase the risk of fractures. Each site of metastasis brings its own set of potential problems and symptoms.[2]

Impact on Daily Life

Living with hepatic angiosarcoma affects nearly every aspect of daily life, from physical capabilities to emotional well-being, social relationships, and the ability to work or enjoy hobbies. Understanding these impacts helps patients and families prepare and adjust.

Physically, hepatic angiosarcoma can cause debilitating fatigue that goes beyond normal tiredness. This exhaustion isn’t relieved by rest and can make even simple daily tasks feel overwhelming. Getting out of bed, preparing meals, or taking a shower may require significant effort. The fatigue stems from multiple sources: the cancer itself, the body’s response to fighting the disease, poor nutrition if eating is difficult, and the effects of treatments like chemotherapy.[2]

Pain is another common physical challenge. The pain might be a dull, constant ache in the upper right abdomen where the liver is located, or it could be sharp and severe, especially if the tumor is pressing on nearby structures or if complications like rupture occur. Managing this pain often requires medications, which themselves can cause side effects like drowsiness or constipation that further impact quality of life.[1]

When the abdomen becomes swollen with fluid accumulation, it can cause physical discomfort and make breathing more difficult, especially when lying down. This can interfere with sleep, leading to further fatigue. The swelling may also make it difficult to find comfortable clothing or positions for sitting and lying down.[1]

Nausea, loss of appetite, and weight loss are frequent problems that affect not just physical health but also social enjoyment. Meals, which are often social occasions, may become unpleasant or impossible. The inability to eat favorite foods or share meals with loved ones can be emotionally distressing and socially isolating.[1]

Emotionally, a diagnosis of hepatic angiosarcoma is devastating. The aggressive nature of the disease and its poor prognosis naturally lead to feelings of fear, anxiety, sadness, and grief. Patients may grieve for the future they expected to have, for plans that now seem uncertain, and for the independence they may lose as the disease progresses. These feelings are normal and valid responses to a life-threatening illness.

Anxiety about the future, about medical procedures and treatments, and about the well-being of loved ones can be constant companions. Some people experience depression, which can make the physical symptoms feel worse and reduce motivation to engage in treatment or self-care. Seeking support from mental health professionals, counselors, or support groups can be helpful in managing these emotional challenges.

The disease often forces changes in social relationships and roles within families. Someone who was previously independent or who took care of others may need to accept help with daily activities. This role reversal can be difficult for everyone involved. Patients may feel guilty about being a burden, while family members may struggle with their own emotions about the situation.

Social activities and hobbies often need to be modified or abandoned. Fatigue, medical appointments, and treatment side effects may make it difficult to maintain previous levels of social engagement. Friends may not know how to respond to the diagnosis, leading to awkward interactions or even withdrawal. Some patients find that their social circle changes, with some friendships fading while new connections form with others facing similar challenges.

Work becomes difficult or impossible for most patients with hepatic angiosarcoma. The physical symptoms, frequent medical appointments, and treatment side effects make maintaining regular employment very challenging. This loss of work can be emotionally difficult, as work often provides a sense of purpose and identity, not to mention financial security. Patients may need to explore disability benefits, medical leave, or early retirement options.

Financial stress is a significant concern for many families dealing with hepatic angiosarcoma. Medical bills accumulate rapidly, while income may decrease if the patient or caregiving family members can’t work. The stress of managing finances while also dealing with a serious illness adds another layer of difficulty to an already challenging situation.

Despite these challenges, many patients find ways to maintain quality of life and find meaning in their remaining time. Some strategies that people have found helpful include:

  • Breaking tasks into smaller, manageable steps and resting between activities
  • Accepting help from others rather than trying to maintain independence at all costs
  • Focusing on activities and relationships that bring joy and meaning
  • Communicating openly with loved ones about feelings and needs
  • Working with palliative care teams to manage symptoms effectively
  • Connecting with support groups where others understand the experience
  • Setting realistic goals for each day rather than expecting pre-illness levels of activity

Palliative care, which focuses on improving quality of life and managing symptoms, can be valuable at any stage of the disease, not just at the end of life. Palliative care teams include doctors, nurses, social workers, and other professionals who work together to address physical symptoms, emotional distress, and practical concerns.

Support for Family

When a loved one is diagnosed with hepatic angiosarcoma, family members often feel overwhelmed and unsure how to help. Understanding what families can do, especially regarding clinical trials and research opportunities, can provide a sense of purpose and practical direction during a difficult time.

Clinical trials are research studies that test new treatments or approaches to diagnosing and managing diseases. For rare and aggressive cancers like hepatic angiosarcoma, where standard treatments have limited effectiveness, clinical trials may offer access to promising new therapies that aren’t yet widely available. They also contribute to medical knowledge that may help future patients.[9]

Families should know that participating in a clinical trial is completely voluntary. No one should feel pressured to enroll, and patients can withdraw from a trial at any time if they choose. The decision should be made based on careful consideration of the potential benefits and risks, in consultation with the patient’s healthcare team.

Finding appropriate clinical trials for hepatic angiosarcoma can be challenging because of the disease’s rarity. Family members can help by researching available trials through online databases and cancer center websites. The patient’s oncologist may also know of relevant trials or can help connect the family with specialists who might be conducting research in this area.

When researching clinical trials, families should look for information about the trial’s phase, eligibility requirements, what treatments are being tested, potential risks and benefits, and the time commitment required. Understanding these details helps in having informed discussions with the patient and their medical team about whether a particular trial might be appropriate.

Preparing for potential trial participation involves several practical steps that families can assist with. This includes gathering comprehensive medical records, ensuring all previous test results and imaging studies are available, and organizing the information in a way that’s easy to share with the trial team. Many trials have specific eligibility criteria based on the stage of disease, previous treatments received, and overall health status, so having this information readily available is crucial.

Families can also help by supporting the patient through the screening and enrollment process if they decide to pursue a trial. This process often involves additional testing to confirm eligibility, detailed informed consent discussions, and potentially travel to specialized medical centers. Having a family member available to attend appointments, take notes, ask questions, and provide emotional support can make this process less overwhelming.

It’s important for families to understand that not all clinical trials are testing experimental drugs. Some may be studying new combinations of existing treatments, different treatment sequences, or comparing various approaches to managing symptoms and side effects. The goal is always to find better ways to help patients.

Beyond clinical trials, families can support their loved one in many practical ways. Transportation to medical appointments becomes increasingly important as the disease progresses and the patient may be unable to drive due to pain, fatigue, or medications. Keeping a calendar of appointments and helping remember which medications to take and when can prevent missed doses and appointments.

Emotional support is equally important as practical help. Being present, listening without judgment, and acknowledging the difficulty of the situation can provide comfort. Sometimes families try to maintain constant positivity or avoid discussing difficult topics, but most patients appreciate the opportunity to express their fears and concerns to someone who cares about them.

Families should also remember to care for themselves. Caring for someone with a serious illness is emotionally and physically exhausting. It’s not selfish to take breaks, seek support for yourself, or ask others to help share caregiving responsibilities. Support groups for family members and caregivers can provide understanding from others in similar situations.

Communication with the healthcare team is another area where families can play a vital role. Patients may not always remember everything discussed during medical appointments, especially when they’re not feeling well or when receiving difficult news. Having a family member present to listen, take notes, and ask questions ensures important information isn’t missed. Some families find it helpful to prepare a list of questions before appointments to make sure their concerns are addressed.

As the disease progresses, families may need to help with more advanced care planning discussions. While these conversations are difficult, they’re important for ensuring the patient’s wishes are known and respected. Topics might include preferences for treatment intensity, where the patient would like to receive care, and what quality of life means to them. Having these discussions early, while the patient can clearly express their wishes, can help guide future decisions.

Based on the provided sources, no registered drugs specifically approved for the treatment of hepatic angiosarcoma were mentioned. The sources discuss treatment approaches including surgery, chemotherapy, immunotherapy (such as ipilimumab/nivolumab), and radiation therapy, but none of these are identified as drugs specifically registered for hepatic angiosarcoma. Therefore, this section is omitted.

Ongoing Clinical Trials on Hepatic angiosarcoma

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    1 1 1
    Investigated drugs:
    Germany

References

https://www.ncbi.nlm.nih.gov/books/NBK538224/

https://www.medicalnewstoday.com/articles/angiosarcoma-liver

https://www.healthline.com/health/cancer/angiocarcinoma-liver

https://en.wikipedia.org/wiki/Liver_angiosarcoma

https://www.ncbi.nlm.nih.gov/sites/books/NBK538224/

https://wjso.biomedcentral.com/articles/10.1186/1477-7819-10-23

https://www.oncoscience.us/news/pr/treatment-options-for-a-rare-tumor-primary-hepatic-angiosarcoma/

https://www.spandidos-publications.com/10.3892/ol.2016.4348

https://pmc.ncbi.nlm.nih.gov/articles/PMC10510833/

https://www.healthline.com/health/cancer/angiocarcinoma-liver

https://www.oncoscience.us/news/pr/treatment-options-for-a-rare-tumor-primary-hepatic-angiosarcoma/

https://www.ncbi.nlm.nih.gov/books/NBK538224/

https://cco.amegroups.org/article/view/139572/html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10510833/

https://www.medicalnewstoday.com/articles/angiosarcoma-liver

https://www.healthline.com/health/cancer/angiocarcinoma-liver

https://my.clevelandclinic.org/health/diseases/22778-angiosarcoma

https://www.cureasc.org/what-is-angiosarcoma/

https://pmc.ncbi.nlm.nih.gov/articles/PMC9379495/

https://mdsearchlight.com/cancer/liver-angiosarcoma/

FAQ

How rare is hepatic angiosarcoma?

Hepatic angiosarcoma is extremely rare, accounting for only 0.1% to 2% of all primary liver cancers. Despite its rarity, it ranks as the third most common type of primary liver malignancy and is the most common primary malignant mesenchymal tumor of the liver in adults.

What are the early warning signs of hepatic angiosarcoma?

Unfortunately, hepatic angiosarcoma often causes no symptoms in its early stages. When symptoms do appear, they are typically vague and non-specific, including abdominal pain in the upper right area, fatigue, weight loss, bloating, and sometimes jaundice. These symptoms can easily be mistaken for other, less serious conditions.

Who is most at risk for developing hepatic angiosarcoma?

Hepatic angiosarcoma typically affects older adults, with peak incidence in people in their 60s and 70s. Men are affected more frequently than women, with a ratio of 3 to 4 men for every woman. People with past exposure to vinyl chloride, thorotrast, arsenic, or certain medications may have increased risk.

Can hepatic angiosarcoma be cured?

Surgical removal of the tumor with clean margins (no cancer cells at the edges) is the only potentially curative treatment for hepatic angiosarcoma. However, most patients are diagnosed when the disease is already too advanced for complete surgical removal, making cure unlikely. Even with surgery, the cancer has a high tendency to recur.

What is the survival rate for hepatic angiosarcoma?

The prognosis for hepatic angiosarcoma is unfortunately poor. The median overall survival is approximately six months from diagnosis. The one-year survival rate is around 30%, the three-year rate is about 8%, and the five-year survival rate is approximately 5%. However, some patients who undergo successful surgery have survived much longer.

🎯 Key Takeaways

  • Hepatic angiosarcoma is the third most common primary liver cancer despite representing less than 2% of all liver tumors
  • Most cases develop with no identifiable cause, though exposure to industrial chemicals decades earlier can be a risk factor
  • Early symptoms are often absent or so vague that the disease is typically diagnosed in advanced stages
  • Spontaneous tumor rupture causing internal bleeding occurs in 15-27% of patients and carries extremely poor prognosis
  • Liver function tests may remain normal even with significant tumor burden, making routine blood work ineffective for early detection
  • Surgery with complete tumor removal is the only potentially curative approach, but few patients are candidates due to late diagnosis
  • The disease has a median survival of six months, though some patients with successful surgery have survived over a decade
  • Clinical trials may offer access to promising new treatments for this rare cancer where standard therapies have limited effectiveness

Connected medications: